Wed, Aug 20, 2014, 4:40 AM EDT - U.S. Markets open in 4 hrs 50 mins


% | $
Quotes you view appear here for quick access.

NPS Pharmaceuticals, Inc. Message Board

  • eyesandears51 eyesandears51 Apr 30, 2013 3:21 PM Flag

    NPSP: Medium/LT Prospects Good.....Near Term Stock May be Overextended

    NPSP stock is correcting amid a broader weakness in the Pharma/Biotech sector. The market stage is framed today by the earnings miss at Pfizer and the weakness of the big three biotech’s, Biogen, GILD, and Celgene. Even high beta Regeneron is retrenching. NPSP stock technical’s are also under stress. RSI is declining. 6 insider sale transactions by CEO, CFO and other officers at prices averaging $ 10, and 1 buy transaction. The stock has very high short interest @ nearly 15%, well above the 10% threshold for concern. One measure of investor expectation is to follow options. The preponderance of volume for May 18 call and put contracts are below $ 11.The stock could test the $ 10.15, 50 day SMA April low this week.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
27.67-0.33(-1.18%)Aug 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.